Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31826 - 31850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	MIR629	693214	upregulated	Cisplatin results in increased expression of MIR629 mRNA	15q23	A22256
Cisplatin	Approved Investigational	MIR630	693215	upregulated	Cisplatin results in increased expression of MIR630 mRNA	15q24.1	A22256
Cisplatin	Approved Investigational	MIR638	693223	upregulated	Cisplatin results in increased expression of MIR638 mRNA	19p13.2	A22256
Cisplatin	Approved Investigational	MIR663A	724033	upregulated	Cisplatin results in increased expression of MIR663A mRNA	20p11.1	A22256
Cisplatin	Approved Investigational	MMP10	4319	upregulated	Cisplatin results in increased expression of MMP10 mRNA	11q22.2	A22251
Cisplatin	Approved Investigational	MMP15	4324	upregulated	Cisplatin results in increased expression of MMP15 mRNA	16q21	A22251
Cisplatin	Approved Investigational	MMP16	4325	upregulated	Cisplatin results in increased expression of MMP16 mRNA	8q21.3	A22251
Cisplatin	Approved Investigational	MMP2	4313	upregulated	Cisplatin results in increased expression of MMP2 mRNA	16q12.2	A22239
Cisplatin	Approved Investigational	MNAT1	4331	downregulated	Cisplatin results in decreased expression of MNAT1 mRNA	14q23.1	A22204
Cisplatin	Approved Investigational	MOK	5891	downregulated	Cisplatin results in decreased expression of MOK mRNA	14q32.31	A22204
Cisplatin	Approved Investigational	MPRIP	23164	downregulated	Cisplatin results in decreased expression of MPRIP mRNA	17p11.2	A22204
Cisplatin	Approved Investigational	MPZL1	9019	downregulated	Cisplatin results in decreased expression of MPZL1 mRNA	1q24.2	A21499
Cisplatin	Approved Investigational	MRM2	29960	downregulated	Cisplatin results in decreased expression of MRM2 mRNA	7p22.3	A21499
Cisplatin	Approved Investigational	MRPL49	740	upregulated	Cisplatin results in increased expression of MRPL49 mRNA	11q13.1	A22204
Cisplatin	Approved Investigational	MSH6	2956	downregulated	Cisplatin results in decreased expression of MSH6 mRNA	2p16.3	A21499
Cisplatin	Approved Investigational	MSMO1	6307	downregulated	Cisplatin results in decreased expression of MSMO1 mRNA	4q32.3	A22203
Cisplatin	Approved Investigational	MT1A	4489	upregulated	Cisplatin results in increased expression of MT1A mRNA	16q13	A22258
Cisplatin	Approved Investigational	MT2A	4502	upregulated	Cisplatin results in increased expression of MT2A mRNA	16q13	A22258 A20427
Cisplatin	Approved Investigational	MT3	4504	upregulated	Cisplatin results in increased expression of MT3 mRNA	16q13	A22213
Cisplatin	Approved Investigational	MTDH	92140	downregulated	Cisplatin results in decreased expression of MTDH mRNA	8q22.1	A20427
Cisplatin	Approved Investigational	MTFP1	51537	upregulated	Cisplatin results in increased expression of MTFP1 mRNA	22q12.2	A20427
Cisplatin	Approved Investigational	MTHFD1L	25902	downregulated	Cisplatin results in decreased expression of MTHFD1L mRNA	6q25.1	A22204
Cisplatin	Approved Investigational	MUT	4594	upregulated	Cisplatin results in increased expression of MUT mRNA	6p12.3	A20464
Cisplatin	Approved Investigational	MVB12B	89853	downregulated	Cisplatin results in decreased expression of MVB12B mRNA	9q33.3	A22211
Cisplatin	Approved Investigational	MVD	4597	downregulated	Cisplatin results in decreased expression of MVD mRNA	16q24.2	A22203

Displaying entries 31826 - 31850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability